Dr. Goldschmidt is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
2600 Research Center Dr
Ste A
Blacksburg, VA 24060Phone+1 540-381-5291Fax+1 540-953-4506
Education & Training
University of RochesterFellowship, Hematology and Medical Oncology, 2003 - 2005- University of RochesterFellowship, Geriatric Medicine (Internal Medicine), 2002 - 2003
- University of RochesterResidency, Internal Medicine, 1999 - 2002
University of North Carolina at Chapel Hill School of MedicineClass of 1998
Certifications & Licensure
VA State Medical License 2005 - 2026
NY State Medical License 2001 - 2005- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Medical Oncology
Clinical Trials
- Phase 1/2 Study of Avutometinib (VS-6766) + Sotorasib With or Without Defactinib in KRAS G12C NSCLC Patients Start of enrollment: 2022 Apr 12
- A Study of Brentuximab Vedotin With Hodgkin Lymphoma (HL) and CD30-expressing Peripheral T-cell Lymphoma (PTCL) Start of enrollment: 2012 Oct 31
- Study of Seribantumab in Adult Patients With NRG1 Gene Fusion Positive Advanced Solid Tumors Start of enrollment: 2020 Sep 29
Publications & Presentations
PubMed
- 232 citationsAtezolizumab Plus Chemotherapy for First-Line Treatment of Nonsquamous NSCLC: Results From the Randomized Phase 3 IMpower132 Trial.Makoto Nishio, Fabrice Barlesi, Howard Jack West, Simon Ball, Rodolfo Bordoni
Journal of Thoracic Oncology. 2021-04-01 - 95 citationsPD-L1 Expression by Two Complementary Diagnostic Assays and mRNA In Situ Hybridization in Small Cell Lung CancerHui Yu, Cory Batenchuk, Andrzej Badzio, Theresa A. Boyle, Piotr Czapiewski
Journal of Thoracic Oncology. 2017-01-01 - 122 citationsAtezolizumab in patients with advanced non-small cell lung cancer and history of asymptomatic, treated brain metastases: Exploratory analyses of the phase III OAK study.Shirish M. Gadgeel, Rimas V. Lukas, J. Goldschmidt, Paul Conkling, Keunchil Park
Lung Cancer. 2019-02-01
Press Mentions
New Publication Highlights Real World Impact of Trilaciclib on Myelosuppressive Events in Patients with Extensive Stage Small Cell Lung Cancer (ES-SCLC)August 2nd, 2023
Research History
- Site research leaderMedical director of research at Blue Ridge Cancer Care2017 - Present
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
